{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:04:14Z","timestamp":1768615454906,"version":"3.49.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Culturing 3D-expanded human placental-derived adherent stromal cells (ASCs) in the presence of tumor necrosis factor-alpha (TNF-\u03b1) and interferon-gamma (IFN-\u03b3) transiently upregulated the secretion of numerous anti-proliferative, anti-angiogenic and pro-inflammatory cytokines. In a 3D-spheroid screening assay, conditioned medium from these induced-ASCs inhibited proliferation of cancer cell lines, including triple-negative breast cancer (TNBC) lines.<jats:italic>In vitro<\/jats:italic>co-culture studies of induced-ASCs with MDA-MB-231 human breast carcinoma cells, a model representing TNBC, supports a mechanism involving immunomodulation and angiogenesis inhibition.<jats:italic>In vivo<\/jats:italic>studies in nude mice showed that intramuscular administration of induced-ASCs halted MDA-MB-231 cell proliferation, and inhibited tumor progression and vascularization. Thirty percent of treated mice experienced complete tumor remission. Murine serum concentrations of the tumor-supporting cytokines Interleukin-6 (IL-6), Vascular endothelial growth factor (VEGF) and Granulocyte-colony stimulating factor (G-CSF) were lowered to na\u00efve levels. A somatic mutation analysis identified numerous genes which could be screened in patients to increase a positive therapeutic outcome. Taken together, these results show that targeted changes in the secretion profile of ASCs may improve their therapeutic potential.<\/jats:p>","DOI":"10.1038\/s41598-017-18428-1","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:18:45Z","timestamp":1515424725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-\u03b1 and IFN-\u03b3 Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models"],"prefix":"10.1038","volume":"8","author":[{"given":"Hoshea","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niva","family":"Shraga-Heled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Dego-Ashto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Fuchs-Telem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Gilert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zami","family":"Aberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Racheli","family":"Ofir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"18428_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","volume":"8","author":"S Cleator","year":"2007","unstructured":"Cleator, S., Heller, W. & Coombes, R. C. Triple-negative breast cancer: therapeutic options. Lancet. Oncol. 8, 235\u201344 (2007).","journal-title":"Lancet. Oncol."},{"key":"18428_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557\u201363 (2007).","journal-title":"Nature"},{"key":"18428_CR3","doi-asserted-by":"publisher","first-page":"e89595","DOI":"10.1371\/journal.pone.0089595","volume":"9","author":"BG Rowan","year":"2014","unstructured":"Rowan, B. G. et al. Human adipose tissue-derived stromal\/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS One 9, e89595 (2014).","journal-title":"PLoS One"},{"key":"18428_CR4","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.1007\/s13277-016-5187-7","volume":"37","author":"F Norozi","year":"2016","unstructured":"Norozi, F., Ahmadzadeh, A., Shahrabi, S., Vosoughi, T. & Saki, N. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells. Tumor Biol. 37, 11679\u201311689 (2016).","journal-title":"Tumor Biol."},{"key":"18428_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","volume":"280","author":"R Ayuzawa","year":"2009","unstructured":"Ayuzawa, R. et al. Na\u00efve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett. 280, 31\u20137 (2009).","journal-title":"Cancer Lett."},{"key":"18428_CR6","doi-asserted-by":"publisher","first-page":"e11140","DOI":"10.1371\/journal.pone.0011140","volume":"5","author":"P Secchiero","year":"2010","unstructured":"Secchiero, P. et al. Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin\u2019s Lymphoma Xenografts. PLoS One 5, e11140 (2010).","journal-title":"PLoS One"},{"key":"18428_CR7","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/00029330-200612020-00013","volume":"119","author":"Z Wu","year":"2006","unstructured":"Wu, Z., Hui, G., Lu, Y., Wu, X. & Guo, L. Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury. Chin. Med. J. (Engl). 119, 2101\u20137 (2006).","journal-title":"Chin. Med. J. (Engl)."},{"key":"18428_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-11-79","volume":"11","author":"T Phermthai","year":"2010","unstructured":"Phermthai, T. et al. A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol. 11, 79 (2010).","journal-title":"BMC Cell Biol."},{"key":"18428_CR9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.20051921","volume":"203","author":"AY Khakoo","year":"2006","unstructured":"Khakoo, A. Y. et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma. J. Exp. Med. 203, 1235\u201347 (2006).","journal-title":"J. Exp. Med."},{"key":"18428_CR10","doi-asserted-by":"publisher","first-page":"e7669","DOI":"10.1371\/journal.pone.0007669","volume":"4","author":"CL Roland","year":"2009","unstructured":"Roland, C. L. et al. Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer. PLoS One 4, e7669 (2009).","journal-title":"PLoS One"},{"key":"18428_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.yexmp.2003.06.001","volume":"75","author":"LB Ohlsson","year":"2003","unstructured":"Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K. & Lindvall, M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp. Mol. Pathol. 75, 248\u201355 (2003).","journal-title":"Exp. Mol. Pathol."},{"key":"18428_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1398-2265.2004.00202.x","volume":"8","author":"SL Gardner","year":"2004","unstructured":"Gardner, S. L. Application of stem cell transplant for brain tumors. Pediatr. Transplant. 8, 28\u201332 (2004).","journal-title":"Pediatr. Transplant."},{"key":"18428_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1593\/neo.09620","volume":"11","author":"JE Koskimaki","year":"2009","unstructured":"Koskimaki, J. E. et al. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia 11, 1285\u201391 (2009).","journal-title":"Neoplasia"},{"key":"18428_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10555-010-9222-7","volume":"29","author":"SA Bergfeld","year":"2010","unstructured":"Bergfeld, S. A. & DeClerck, Y. A. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 29, 249\u2013261 (2010).","journal-title":"Cancer Metastasis Rev."},{"key":"18428_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.5966\/sctm.2015-0300","volume":"5","author":"H Zheng","year":"2016","unstructured":"Zheng, H. et al. Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth. Stem Cells Transl. Med. 5, 1216\u201328 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"18428_CR16","doi-asserted-by":"publisher","unstructured":"Yu, P. F. et al. TNFa-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene 1\u20139, https:\/\/doi.org\/10.1038\/onc.2016.217 (2016).","DOI":"10.1038\/onc.2016.217"},{"key":"18428_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.biocel.2012.04.015","volume":"44","author":"J Du","year":"2012","unstructured":"Du, J. et al. IFN-g-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. Int. J. Biochem. Cell Biol. 44, 1305\u20131314 (2012).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"18428_CR18","first-page":"318098","volume":"2014","author":"X Yang","year":"2014","unstructured":"Yang, X., Du, J., Xu, X., Xu, C. & Song, W. IFN-g-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway. J. Immunol. Res. 2014, 318098 (2014).","journal-title":"J. Immunol. Res."},{"key":"18428_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.stem.2012.10.001","volume":"11","author":"RH Lee","year":"2012","unstructured":"Lee, R. H., Yoon, N., Reneau, J. C. & Prockop, D. J. Preactivation of human MSCs with TNF-a enhances tumor-suppressive activity. Cell Stem Cell 11, 825\u201335 (2012).","journal-title":"Cell Stem Cell"},{"key":"18428_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10549-011-1774-x","volume":"133","author":"Y Ma","year":"2012","unstructured":"Ma, Y., Hao, X., Zhang, S. & Zhang, J. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res. Treat. 133, 473\u2013485 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"18428_CR21","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1016\/j.biomaterials.2014.03.014","volume":"35","author":"L Leng","year":"2014","unstructured":"Leng, L. et al. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy. Biomaterials 35, 5162\u20135170 (2014).","journal-title":"Biomaterials"},{"key":"18428_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13287-015-0003-7","volume":"6","author":"AV Meleshina","year":"2015","unstructured":"Meleshina, A. V. et al. Influence of mesenchymal stem cells on metastasis development in mice in vivo. Stem Cell Res. Ther. 6, 15 (2015).","journal-title":"Stem Cell Res. Ther."},{"key":"18428_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10549-006-9463-x","volume":"105","author":"RS Finn","year":"2007","unstructured":"Finn, R. S. et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type\/\u2018triple-negative\u2019 breast cancer cell lines growing in vitro. Breast Cancer Res. Treat. 105, 319\u201326 (2007).","journal-title":"Breast Cancer Res. Treat."},{"key":"18428_CR24","doi-asserted-by":"publisher","first-page":"e45590","DOI":"10.1371\/journal.pone.0045590","volume":"7","author":"RS Waterman","year":"2012","unstructured":"Waterman, R. S., Henkle, S. L. & Betancourt, A. M. Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis. PLoS One 7, e45590 (2012).","journal-title":"PLoS One"},{"key":"18428_CR25","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman, R. S., Tomchuck, S. L., Henkle, S. L. & Betancourt, A. M. A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype. PLoS One 5, e10088 (2010).","journal-title":"PLoS One"},{"key":"18428_CR26","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jcyt.2015.06.009","volume":"17","author":"N Yoon","year":"2015","unstructured":"Yoon, N., Park, M. S., Peltier, G. C. & Lee, R. H. Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice. Cytotherapy 17, 1332\u201341 (2015).","journal-title":"Cytotherapy"},{"key":"18428_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/scd.2009.0404","volume":"19","author":"O Parolini","year":"2010","unstructured":"Parolini, O. et al. Toward Cell Therapy Using Placenta-Derived Cells: Disease Mechanisms, Cell Biology, Preclinical Studies, and Regulatory Aspects at the Round Table. Stem Cells Dev. 19, 143\u2013154 (2010).","journal-title":"Stem Cells Dev."},{"key":"18428_CR28","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.1016\/j.placenta.2011.04.017","volume":"32","author":"O Parolini","year":"2011","unstructured":"Parolini, O. et al. Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). Placenta 32, S285\u2013S290 (2011).","journal-title":"Placenta"},{"key":"18428_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/14653240902849762","volume":"11","author":"WR Prather","year":"2009","unstructured":"Prather, W. R. et al. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 11, 427\u2013434 (2009).","journal-title":"Cytotherapy"},{"key":"18428_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.addr.2011.06.010","volume":"64","author":"K Shah","year":"2012","unstructured":"Shah, K. Mesenchymal stem cells engineered for cancer therapy. Adv. Drug Deliv. Rev. 64, 739\u2013748 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"18428_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2014.0026","volume":"35","author":"M Esquivel-Vel\u00e1zquez","year":"2015","unstructured":"Esquivel-Vel\u00e1zquez, M. et al. The Role of Cytokines in Breast Cancer Development and Progression. J. Interf. Cytokine Res. 35, 1\u201316 (2015).","journal-title":"J. Interf. Cytokine Res."},{"key":"18428_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cmi.2015.11","volume":"13","author":"G-Y Liu","year":"2016","unstructured":"Liu, G.-Y. et al. Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential. Cell. Mol. Immunol. 13, 369\u2013378 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"18428_CR33","doi-asserted-by":"publisher","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","volume":"42","author":"D Croft","year":"2014","unstructured":"Croft, D. et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 42, D472\u2013D477 (2014).","journal-title":"Nucleic Acids Res."},{"key":"18428_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/cancers4041180","volume":"4","author":"M Milacic","year":"2012","unstructured":"Milacic, M. et al. Annotating cancer variants and anti-cancer therapeutics in Reactome. Cancers (Basel). 4, 1180\u20131211 (2012).","journal-title":"Cancers (Basel)."},{"key":"18428_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08830180902978120","volume":"28","author":"F Zhou","year":"2009","unstructured":"Zhou, F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 28, 239\u201360 (2009).","journal-title":"Int. Rev. Immunol."},{"key":"18428_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/scbi.2001.0404","volume":"12","author":"B Seliger","year":"2002","unstructured":"Seliger, B., Cabrera, T., Garrido, F. & Ferrone, S. HLA class I antigen abnormalities and immune escape by malignant cells. Semin. Cancer Biol. 12, 3\u201313 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"18428_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1357-4310(99)01451-3","volume":"5","author":"DJ Hicklin","year":"1999","unstructured":"Hicklin, D. J., Marincola, F. M. & Ferrone, S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol. Med. Today 5, 178\u201386 (1999).","journal-title":"Mol. Med. Today"},{"key":"18428_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1385\/IR:33:2:113","volume":"33","author":"RL Ferris","year":"2005","unstructured":"Ferris, R. L., Hunt, J. L. & Ferrone, S. Human Leukocyte Antigen (HLA) Class I Defects in Head and Neck Cancer: Molecular Mechanisms and Clinical Significance. Immunol. Res. 33, 113\u2013134 (2005).","journal-title":"Immunol. Res."},{"key":"18428_CR39","doi-asserted-by":"publisher","first-page":"e102878","DOI":"10.1371\/journal.pone.0102878","volume":"9","author":"ME Arellano-Garcia","year":"2014","unstructured":"Arellano-Garcia, M. E., Misuno, K., Tran, S. D. & Hu, S. Interferon-g Induces Immunoproteasomes and the Presentation of MHC I-Associated Peptides on Human Salivary Gland Cells. PLoS One 9, e102878 (2014).","journal-title":"PLoS One"},{"key":"18428_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Lempicki, R. A., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"18428_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1\u201313 (2009).","journal-title":"Nucleic Acids Res."},{"key":"18428_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1089\/10430340050015996","volume":"11","author":"CL Addison","year":"2000","unstructured":"Addison, C. L. et al. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum. Gene Ther. 11, 247\u201361 (2000).","journal-title":"Hum. Gene Ther."},{"key":"18428_CR43","doi-asserted-by":"crossref","first-page":"16430","DOI":"10.18632\/oncotarget.14857","volume":"8","author":"S Davidi","year":"2017","unstructured":"Davidi, S. et al. The antiangiogenic role of the pro-inflammatory cytokine interleukin-31. Oncotarget 8, 16430\u201316444 (2017).","journal-title":"Oncotarget"},{"key":"18428_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.144","volume":"6","author":"M Yang","year":"2015","unstructured":"Yang, M., Liu, J., Piao, C., Shao, J. & Du, J. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis. Cell Death Dis. 6, e1780 (2015).","journal-title":"Cell Death Dis."},{"key":"18428_CR45","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/onc.2012.126","volume":"32","author":"HX Zheng","year":"2013","unstructured":"Zheng, H. X. et al. Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer. Oncogene 32, 1183\u201392 (2013).","journal-title":"Oncogene"},{"key":"18428_CR46","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1002\/eji.201242505","volume":"43","author":"L Hannesd\u00f3ttir","year":"2013","unstructured":"Hannesd\u00f3ttir, L. et al. Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. Eur. J. Immunol. 43, 2718\u201329 (2013).","journal-title":"Eur. J. Immunol."},{"key":"18428_CR47","doi-asserted-by":"crossref","unstructured":"Hensbergen, P. J. et al. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. J. Immunother. 28, 343\u201351 (2005).","DOI":"10.1097\/01.cji.0000165355.26795.27"},{"key":"18428_CR48","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/CJI.0b013e318031b551","volume":"30","author":"TC Walser","year":"2007","unstructured":"Walser, T. C. et al. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model. J. Immunother. 30, 490\u20138 (2007).","journal-title":"J. Immunother."},{"key":"18428_CR49","doi-asserted-by":"publisher","first-page":"e1091554","DOI":"10.1080\/2162402X.2015.1091554","volume":"5","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy. Oncoimmunology 5, e1091554 (2016).","journal-title":"Oncoimmunology"},{"key":"18428_CR50","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","volume":"187","author":"KE Cole","year":"1998","unstructured":"Cole, K. E. et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009\u201321 (1998).","journal-title":"J. Exp. Med."},{"key":"18428_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163\u201389 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"18428_CR52","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1089\/10430349950017130","volume":"10","author":"SE Braun","year":"1999","unstructured":"Braun, S. E. et al. Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action. Hum. Gene Ther. 10, 2141\u201351 (1999).","journal-title":"Hum. Gene Ther."},{"key":"18428_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","volume":"19","author":"Q Zhang","year":"2008","unstructured":"Zhang, Q., Putheti, P., Zhou, Q., Liu, Q. & Gao, W. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev. 19, 347\u201356 (2008).","journal-title":"Cytokine Growth Factor Rev."},{"key":"18428_CR54","doi-asserted-by":"publisher","first-page":"e1014232","DOI":"10.1080\/2162402X.2015.1014232","volume":"4","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma. Oncoimmunology 4, e1014232 (2015).","journal-title":"Oncoimmunology"},{"key":"18428_CR55","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1016\/j.febslet.2008.11.019","volume":"582","author":"K Chakrabandhu","year":"2008","unstructured":"Chakrabandhu, K., Huault, S. & Hueber, A.-O. Distinctive molecular signaling in triple-negative breast cancer cell death triggered by hexadecylphosphocholine (miltefosine). FEBS Lett. 582, 4176\u201384 (2008).","journal-title":"FEBS Lett."},{"key":"18428_CR56","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/BF02978210","volume":"28","author":"JH Kang","year":"2005","unstructured":"Kang, J. H. et al. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch. Pharm. Res. 28, 1263\u20139 (2005).","journal-title":"Arch. Pharm. Res."},{"key":"18428_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/path.4546","volume":"236","author":"M Suarez-Carmona","year":"2015","unstructured":"Suarez-Carmona, M. et al. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. J. Pathol. 236, 491\u2013504 (2015).","journal-title":"J. Pathol."},{"key":"18428_CR58","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci, D. & Colombatti, A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014, 292376 (2014).","journal-title":"Mediators Inflamm."},{"key":"18428_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/cmi.2012.69","volume":"10","author":"D Lv","year":"2013","unstructured":"Lv, D., Zhang, Y., Kim, H.-J., Zhang, L. & Ma, X. CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Cell. Mol. Immunol. 10, 303\u201310 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"18428_CR60","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1517\/14712591003657128","volume":"10","author":"N Lapteva","year":"2010","unstructured":"Lapteva, N. & Huang, X. F. CCL5 as an adjuvant for cancer immunotherapy. Expert Opin. Biol. Ther. 10, 725\u201333 (2010).","journal-title":"Expert Opin. Biol. Ther."},{"key":"18428_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson, R., Broglie, J. J., Adcock, A. F. & Yang, L. Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors. Assay Drug Dev. Technol. 12, 207\u2013218 (2014).","journal-title":"Assay Drug Dev. Technol."},{"key":"18428_CR62","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1054\/bjoc.2000.1437","volume":"83","author":"AJ Hayes","year":"2000","unstructured":"Hayes, A. J. et al. Expression and function of angiopoietin-1 in breast cancer. Br. J. Cancer 83, 1154\u201360 (2000).","journal-title":"Br. J. Cancer"},{"key":"18428_CR63","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/0192623309338383","volume":"37","author":"Y Ramot","year":"2009","unstructured":"Ramot, Y., Meiron, M., Toren, A., Steiner, M. & Nyska, A. Safety and Biodistribution Profile of Placental-derived Mesenchymal Stromal Cells (PLX-PAD) Following Intramuscular Delivery. Toxicol. Pathol. 37, 606\u2013616 (2009).","journal-title":"Toxicol. Pathol."},{"key":"18428_CR64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nano.2016.09.013","volume":"13","author":"R Meir","year":"2017","unstructured":"Meir, R. et al. Design principles for noninvasive, longitudinal and quantitative cell tracking with nanoparticle-based CT imaging. Nanomedicine Nanotechnology, Biol. Med. 13, 421\u2013429 (2017).","journal-title":"Nanomedicine Nanotechnology, Biol. Med."},{"key":"18428_CR65","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.4049\/jimmunol.161.12.6845","volume":"161","author":"LA Cornelius","year":"1998","unstructured":"Cornelius, L. A. et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161, 6845\u201352 (1998).","journal-title":"J. Immunol."},{"key":"18428_CR66","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0092-8674(00)81926-1","volume":"88","author":"Z Dong","year":"1997","unstructured":"Dong, Z., Kumar, R., Yang, X. & Fidler, I. J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801\u201310 (1997).","journal-title":"Cell"},{"key":"18428_CR67","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.cr.7290176","volume":"13","author":"LJ Metheny-Barlow","year":"2003","unstructured":"Metheny-Barlow, L. J. & Li, L. Y. The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res. 13, 309\u201317 (2003).","journal-title":"Cell Res."},{"key":"18428_CR68","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/bioinformatics\/btl196","volume":"22","author":"J Gould","year":"2006","unstructured":"Gould, J., Getz, G., Monti, S., Reich, M. & Mesirov, J. P. Comparative gene marker selection suite. Bioinformatics 22, 1924\u20131925 (2006).","journal-title":"Bioinformatics"},{"key":"18428_CR69","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500\u20131 (2006).","journal-title":"Nat. Genet."},{"key":"18428_CR70","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013307 (2012).","journal-title":"Nature"},{"key":"18428_CR71","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1093\/nar\/gni179","volume":"33","author":"M Dai","year":"2005","unstructured":"Dai, M. et al. Evolving gene\/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175 (2005).","journal-title":"Nucleic Acids Res."},{"key":"18428_CR72","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes, S. A. et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805\u201311 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18428-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18428-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18428-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T13:32:06Z","timestamp":1693402326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18428-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18428"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18428-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"6 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are current and former employees and shareholders of Pluristem Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"670"}}